甲状腺乳头状癌RASSF1A启动子异常甲基化的检测

为了研究甲状腺乳头状癌组织中RASSF1A基因启动子区甲基化状态,探讨其甲基化与临床参数之间的关系,运用甲基化特异性PCR(MSP)技术,对51例甲状腺乳头状癌组织及10例正常甲状腺组织中RASSF1A基因的甲基化状况进行分析。结果表明:甲状腺乳头状癌组织中RASSF1A基因甲基化率为68.6%(35/51),而正常甲状腺组织中未检测到该基因的甲基化,两者之间的差异有统计学意义(P<0.05);RASSF1A基因甲基化与患者年龄、性别无相关性与肿瘤的浸润和转移有相关性,差异有统计学意义(P<0.05)。因此,RASSF1A基因甲基化是甲状腺乳头状癌组织中常见的分子生物学事件,在腺癌的发生发展过程中发挥重要作用。     

牙龈癌PTEN基因启动子区甲基化状态与鳞癌分级的分析研究

探讨第10号染色体丢失性的磷酸酶——张力蛋白同源基因(PTEN)启动子甲基化水平和蛋白表达水平与牙龈癌癌症细胞分化程度的关系。用甲基化特异性PCR法检测牙龈癌组织中PTEN基因启动子甲基化的状态,免疫组化法检测石蜡组织中PTEN的蛋白表达情况。结果牙龈癌组织中发生PTEN基因甲基化的频率为56.67%,其中高分化组甲基化频率为20%,中分化组为50%,低分化组为100%,组间差异具有统计学意义(P0.05),PTEN甲基化频率与其细胞分化程度密切相关。说明牙龈癌中PTEN基因可出现启动子甲基化,且低分化组牙龈癌PTEN甲基化频率更高,同时细胞内PTEN蛋白表达显著下调甚至缺失,为牙龈癌的靶向治疗提供线索。     

抑癌基因ING1在鼻咽癌中的表达及突变分析

本研究运用免疫组化技术、逆转录 - PCR( RT- PCR) ,PCR- SS-CP技术对鼻咽癌组织及鼻咽癌细胞系中 ING1的表达和突变进行检测 .结果发现 3 0例鼻咽癌标本中 ING1蛋白表达下调率为 70 % ( 2 1/ 3 0 ) ;ING1m RNA表达明显下调率为 4 6% ( 12 / 2 6) ,6例鼻咽癌细胞系中有 2例鼻咽癌细胞系表达明显下调 ,而 11例 ( 4 2 .5 % ) NPC组织及其它 4例细胞系表达与正常水平相当 ,另有 3例 ( 11.5 % )鼻咽癌组织过表达 ;单链构像多态性分析 ( SSCP)在鼻咽癌及鼻咽癌细胞系中均未发现突变 .结果表明ING1基因的转录及翻译表达水平与鼻咽癌的发生 /发展呈负相关 ,该基因的异常表达是鼻咽癌发生中的频发事件而与基因突变无关     

dDnmt2与dMBD2/3在果蝇不同发育时期的转录表达

为了深入了解果蝇DNA甲基化修饰系统及其相关基因的表达特点及功能,以黑腹果蝇Canton S品系为材料,应用实时荧光定量PCR方法检测分析不同发育时期果蝇dDnmt2与dMBD2/3基因的转录表达.结果表明:dDnmt2与dMBD2/3分别在6～9 h和0-3 h胚胎期表达量最高,在12～15 h和18～21 h胚胎、三龄幼虫、蛹、成虫期表达明显降低.果蝇dDnmt2和dMBD2/3基因的表达特点与果蝇不同发育时期基因组DNA甲基化水平相一致.     

通过遗传转化获得含多基因的水稻转基因纯合植株

利用基因枪法将含有4个不同基因的3个质粒共转化由粳稻品种鄂宜105号和鄂晚5号种子胚诱导的愈伤组织（5－10d龄）。从轰击的986块愈合组织中共再生出169株独立的转基因水稻植株（转化率为17％）。PCR／Southern blot分析显示70％以上的转基因植株含有所有4个基因。GUS组织化学分析、Western blot和或RT－PCR分析表明所有4个基因的共表达率为70％。未观察到任何质粒在整合中存在优势,转基因拷贝数也与基因表达量无关。遗传分析证实外源基因在后代植株中大多以孟德尔方式遗传。从其R1代为3：1孟德尔方式遗传的后代R2代植株中,鉴定含有3个或4个不同基因的转基因纯合植株系。PCR／Southern blot分析证实了这些转基因纯合植株系。这些系的植株具有相似的外源基因表达量。我们证实通过基因枪介导的共转化,结合常规育种方法筛选可以获得含多基因的转基因水稻纯合植株。这项技术为利用基因同时改良作用多个性状提供了一种途径。     

Suppression of murine breast cancer metastasis by selective inhibition of CXCR4 by synthetic polypeptide derived from viral macrophage inflammatory protein II

Stromal cell-derived factor-1 and its receptor CXC chemokine receptor-4 (CXCR4) have been implicated in breast cancer metastasis. A significant association between HER2 and CXCR4 expression has been observed in human breast tumor tissues, and overexpression of CXCR4 is essential for HER2-mediated tumor metastasis. Moreover, CXCR4 expression is low in normal breast tissues and high in malignant tumors, suggesting that a blockade of CXCR4 may limit tumor metastasis. The present study investigated the action of a synthetic antagonist 21-mer peptide derived from viral macrophage inflammatory protein II against CXCR4 (NT21MP) in inhibiting metastasis in vitro and in vivo. The results showed that chemotaxis of SKBR3 cells toward SDF-1α was reduced by NT21MP in a dose-dependent manner (P < 0.05). NT21MP inhibited tumor growth at 500 μg/kg and in combination with Herceptin, the anti-HER2 antibody. The in vivo metastatic assay showed that NT21MP significantly inhibited pulmonary metastasis, and the number of metastatic tumor nodes on the surface of the lung was greatly decreased. Compared with the saline-treated control group, PCNA expression was dose-dependently decreased by NT21MP, the percentage of apoptotic cells was increased, and CXCR4 mRNA and protein expression were downregulated. In conclusion, NT21MP inhibits cellular prolifer-ation, promotes apoptosis by downregulating CXCR4 expression, and suppresses the progression of primary and metastatic tumors. CXCR4 may be a useful therapeutic target for breast cancer, and NT21MP may serve as a potential target drug for the treatment of breast cancer metastasis.     

Cyclin D1与p21WAF1在鼻咽癌中的表达

目的探讨鼻咽上皮癌变过程中周期蛋白CyclinD1与抑癌基因p21（wild—type p53 activated fragment 1,p21wAF1）蛋白的表达及其意义。方法应用免疫组化方法检测47例鼻咽癌组织、21例癌旁上皮组织和14例正常鼻咽粘膜中Cyclin D1与p21WAF1蛋白表达。结果从鼻咽正常粘膜、癌旁粘膜上皮组织到癌组织,Cyclin D1表达阳性率逐渐增加,并且差异有显著意义（均为P〈0．05）。p21WAF1蛋白在以上组织中阳性率较高,且各组间差异无显著性。结论Cyclin D1、p21WAF1蛋白与鼻咽部上皮细胞恶性增生密切相关,p21wA兀蛋白表达可能与细胞周期调控的反馈机制有关。     

血浆p16基因甲基化在原发性肝细胞癌诊断中的作用

用甲基化特异性-多聚酶链反应（MSP）方法, 检测原发性肝细胞癌（HCC）、 肝硬 化、 慢性肝炎病人及健 康人各30例的血浆DNA甲基化的p16基因. 结果显示, HCC病人血浆p16 基因甲基化率为67%, 慢性肝炎、 肝硬化及健康者未发生甲基化.     

胃癌中p53基因失活及其蛋白产物的免疫组化分析

应用ＰＣＲ－ＳＳＣＰ银染，Ｓｏｕｔｈｅｒｎ杂我及免疫组化等方法同步研究２５例胃癌标本的ｐ５３基因突变，杂合性丢失及蛋白持表达，在２２例胃癌中同时获得有关ｐ５３基因突变和杂合性丢失的检测结果，被检出ｐ５３基因突变的５例胃癌中，２例伴有杂合性丢失，３例仅有ｐ５３基因突变。     

米根霉L-乳酸脱氢酶基因的克隆及在大肠杆菌中的表达

文章以米根霉基因组DNA为模板,根据已公布的米根酶L-乳酸脱氢酶基因(ldnL)序列设计引物,PCR扩增得到含有ldnL的DNA片段;PCR产物T/A克隆后再双酶切,将ldnL片段连接到大肠杆菌表达载体pET17b,得到重组表达质粒pET17b-ldnL;pET17b-ldnL转化大肠杆菌BL21(DE3),摇瓶培养诱导表达后的菌体经SDS-PAGE电泳分析,结果表明克隆的ldnL基因在大肠杆菌中实现表达。     

基于低氧-免疫DNA甲基化标记在肺腺癌预后中的开发

为了探究缺氧和免疫联合分析DNA甲基化位点在肺癌预后中的作用，提高肺癌免疫治疗的有效性，本研究基于甲基化和转录组二维数据，构建了一个用于预后评估的风险评分模型．从TCGA数据库中下载了247个与缺氧、免疫状态相关的去冗余肺癌样本作为训练集．然后对低缺氧-强免疫状态的样本、高缺氧-弱免疫状态的样本进行了差异基因表达、甲基化位点和临床生存率分析．生存曲线分析显示，低缺氧状态-强免疫状态组中的肺腺癌患者的1、3、5年生存率均优于高缺氧状态-弱免疫状态组（log-rank检验，P<0.05、P<0.001、P<0.001）．使用LASSO回归构建的多基因预后模型包含9个甲基化位点，在肺腺癌测试数据集和验证数据集中均显示出良好的预后预测能力（AUC=0.83,0.80,0.82）．这9个甲基化位点分别分布在PEBP4、FLI1、HLA-DMB、MYO1F、ABCC2、AKNA、ETS1、CCR7和TXNRD1基因上．此外，我们从5年生存曲线中发现，在低缺氧-强免疫状态组中高表达的PEBP4、CCR7、FLI1、AKNA、HLA-DMB、MYO1F和低表达的ABCC2基因也可作为...     

miR-143-3p通过调节TGIF2的表达在甲状腺癌中的作用研究

目的 探究过表达miR-143-3p对甲状腺癌(thyroid cancer,TC)细胞的影响及其作用机制.方法 Real-time PCR分析正常甲状腺上皮细胞和不同TC细胞中miR-143-3p的表达.Targetscan网站和双荧光素酶报告系统验证miR-143-3p和TGIF23′UTR的靶向关系;Real-t...     

Diagnosis of Hepatocellular Carcinoma by Using Methylation Specific-PCR

To find a more sensitive and earlier diagnostic marker for hepatocellular carcinoma, methylation-profils of CpG islands in the promoter of eleven genes in hepatocellular carcinoma（HCC） carcinoma and pericarcinoma tissues from ten patients were examined by using methylation-specific PCR （MSP） method. MSP was used to detect the methylation of p16, p53, Secreted frizzled-related protein 1 （SFRP 1） and SFRP2 promoters. Meanwhile, plasma alpha-fetoprotein （AFP） levels in 53 patients were also determined. The results showed that HCC was closely correlated to methylation in promoter of tumor-suppressing gene p16, p53, SFRP1 and SFRP2. The results suggest that methylation of SFRP2 promoter is possible a better marker for diagnosis of HCC than plasma Alpha-fetoprotein （AFP） levels. The false negative of SFRP1 and SFRP2 are perfectly complementary. If SFRP1 and SFRP2 were both considered as a complementary positive marker at the same time, the accurate rate for diagnosis of HCC is 100%.     

人心室肌球蛋白轻链1基因的克隆及其体外的表达与纯化

通过聚合酶链式反应方法扩增人心室肌球蛋白轻链1的基因片段,并将其克隆到pET-22b质粒,构建表达重组体,转化大肠杆菌BL21细胞,转化子细胞经IPTG诱导,目的蛋白在大肠杆菌中得到高效表达,凝胶成像扫描检测,其表达量接近细胞总蛋白的40%,经Ni2+亲和层析使目的蛋白得到纯化。     

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

Metastatic melanoma is a deadly cancer that fails to respond to conventional chemotherapy and is poorly understood at the molecular level. p53 mutations often occur in aggressive and chemoresistant cancers but are rarely observed in melanoma. Here we show that metastatic melanomas often lose Apaf-1, a cell-death effector that acts with cytochrome c and caspase-9 to mediate p53-dependent apoptosis. Loss of Apaf-1 expression is accompanied by allelic loss in metastatic melanomas, but can be recovered in melanoma cell lines by treatment with the methylation inhibitor 5-aza-2'-deoxycytidine (5aza2dC). Apaf-1-negative melanomas are invariably chemoresistant and are unable to execute a typical apoptotic programme in response to p53 activation. Restoring physiological levels of Apaf-1 through gene transfer or 5aza2dC treatment markedly enhances chemosensitivity and rescues the apoptotic defects associated with Apaf-1 loss. We conclude that Apaf-1 is inactivated in metastatic melanomas, which leads to defects in the execution of apoptotic cell death. Apaf-1 loss may contribute to the low frequency of p53 mutations observed in this highly chemoresistant tumour type.